Compare ARK Genomic Revolution ETF (ARKG) vs Rigetti Computing Inc (RGTI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Rigetti Computing Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Rigetti Computing Inc trades at $16.28 (market cap $5.50B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Rigetti Computing Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | RGTI | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $56.34 |
52-Week Low | $23.09 | $12.18 |
Market Cap | — | $5.50B |
Enterprise Value | — | $5.09B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Rigetti Computing (RGTI) trades at $16.54, down 2.65% on the day, with a bearish technical signal despite recent earnings beats. The company shows severe financial strain with a net income margin of -2,253.59% and negative cash flow from operations of -$58.54M in 2025, though it maintains a debt-free position with $569M cash. Analyst consensus remains strongly bullish with 85.71% buy ratings and a $32.67 price target, highlighting government funding and quantum computing advancements as key catalysts.
The stock presents high-risk, high-reward potential driven by speculative quantum technology growth versus fundamental weaknesses. Near-term risks include cash burn sustainability and commercial adoption timelines, while upside hinges on execution against long-term quantum roadmaps and competitive positioning in a nascent industry.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Rigetti Computing Inc
Rigetti Computing, Inc. is a pioneer in quantum computing, focusing on developing and deploying quantum-classical computing systems. The company designs and fabricates superconducting quantum processors and integrates them with a full-stack software and control platform. Rigetti offers access to its quantum computers through the cloud, aiming to solve complex computational problems that are intractable for classical computers, with applications in finance, chemistry, and machine learning.
Read more on RGTI →
